RUBICON Share Price | Rubicon Research Ltd Stock Analysis & Recommendation

Q: Why is Rubicon Research Ltd falling/rising?

As of 16-Mar, Rubicon Research Ltd's stock price is falling, currently at 745.00, which reflects a decrease of 22.4 points or 2.92%. This decline is part of a broader trend, as the stock has underperformed its sector by 1.8% today and has experienced consecutive losses over the past two days, totaling a drop of 6.61% in that period. The stock reached an intraday low of Rs 745, indicating significant selling pressure.In terms of performance relative to the market, the stock has shown a negative return of 2.42% over the past week, while the benchmark Sensex has declined by 2.66%. Over the past month, Rubicon Research Ltd has decreased by 6.12%, compared to a 9.34% drop in the Sensex. Despite a year-to-date gain of 9.91%, the recent performance suggests a shift in investor sentiment.Additionally, while there has been a rise in investor participation, with delivery volume increasing by 36.5% against the 5-day average, the stock's moving averages indicate that it is currently lower than the 5-day and 20-day moving averages, although it remains above the 50-day, 100-day, and 200-day moving averages. This mixed technical picture, combined with the recent price drop, suggests that the stock is facing downward pressure in the short term.

Technical Trend Update: Rubicon Research witnessed a change in Technical Grade on 23 Mar 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

4.32 lacs (84.83%) Volume

Shareholding (Dec 2025)

FII

7.99%

Held by 42 FIIs

DII

2.44%

Held by 11 DIIs

Promoter

59.99%

When is the next results date for Rubicon Research Ltd?

28-Jan-2026

The next results date for Rubicon Research Ltd is 03 February 2026.

View full answer

Why is Rubicon Research Ltd falling/rising?

17-Mar-2026

As of 16-Mar, Rubicon Research Ltd's stock price is at 745.00, reflecting a decline of 2.92% and consecutive losses totaling 6.61% over the past two days. Despite a year-to-date gain of 9.91%, recent performance indicates downward pressure and a shift in investor sentiment.

View full answer

Which are the latest news on Rubicon Research?

25-Mar-2026

When is the next results date for Rubicon Research Ltd?

Compare Rubicon Research with Similar Stocks

Alembic Pharma Caplin Point Lab Jubilant Pharmo

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 13,085 Cr (Small Cap)

P/E

61.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.60

Return on Equity

22.13%

Price to Book

17.19

Revenue and Profits:

Net Sales:

476 Cr

(Quarterly Results - Dec 2025)

Net Profit:

73 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

14.43%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Rubicon Research for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Rubicon Research Ltd?

The next results date for Rubicon Research Ltd is scheduled for 03 February 2026....

Read full news article

Announcements

Shareholder Meeting / Postal Ballot-Scrutinizers Report

16-Mar-2026 | Source : BSE

Scrutinizers Report

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

16-Mar-2026 | Source : BSE

Outcome of Postal Ballot

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Feb-2026 | Source : BSE

Newspaper Publication - Notice of Postal Ballot

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

6.94

Debt to EBITDA (avg)

1.56

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.27

Tax Ratio

24.96%

Dividend Payout Ratio

0.23%

Pledged Shares

Institutional Holding

17.44%

ROCE (avg)

22.12%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

16.83

EV to EBIT

55.47

EV to EBITDA

48.89

EV to Capital Employed

10.92

EV to Sales

12.29

PEG Ratio

Dividend Yield

ROCE (Latest)

19.68%

ROE (Latest)

22.13%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bearish

Bollinger Bands

Mildly Bullish

KST

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (6.61%)

FIIs

Held by 42 FIIs (7.99%)

Promoter with highest holding

General Atlantic Singapore Rr Pte Ltd (35.97%)

Highest Public shareholder

Shivanand Shankar Mankekar Huf (13.57%)

Individual Investors Holdings

2.71%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -10.33% vs 21.02% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -18.84% vs 30.33% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "301.71",
          "val2": "336.47",
          "chgp": "-10.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "62.24",
          "val2": "79.11",
          "chgp": "-21.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.51",
          "val2": "9.21",
          "chgp": "-18.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "37.18",
          "val2": "45.81",
          "chgp": "-18.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.63%",
          "val2": "23.51%",
          "chgp": "-2.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "614.49",
          "val2": "528.16",
          "chgp": "16.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "142.24",
          "val2": "144.68",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.06",
          "val2": "16.26",
          "chgp": "11.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "80.96",
          "val2": "89.04",
          "chgp": "-9.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.15%",
          "val2": "27.39%",
          "chgp": "-4.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "916.20",
          "val2": "773.03",
          "chgp": "18.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "204.48",
          "val2": "208.58",
          "chgp": "-1.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "25.57",
          "val2": "23.51",
          "chgp": "8.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "118.14",
          "val2": "127.27",
          "chgp": "-7.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.32%",
          "val2": "26.98%",
          "chgp": "-4.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,073.84",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "269.89",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "34.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "167.54",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.13%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

301.71

336.47

-10.33%

Operating Profit (PBDIT) excl Other Income

62.24

79.11

-21.32%

Interest

7.51

9.21

-18.46%

Exceptional Items

0.00

Standalone Net Profit

37.18

45.81

-18.84%

Operating Profit Margin (Excl OI)

20.63%

23.51%

-2.88%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -10.33% vs 21.02% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -18.84% vs 30.33% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

614.49

528.16

16.35%

Operating Profit (PBDIT) excl Other Income

142.24

144.68

-1.69%

Interest

18.06

16.26

11.07%

Exceptional Items

0.00

Standalone Net Profit

80.96

89.04

-9.07%

Operating Profit Margin (Excl OI)

23.15%

27.39%

-4.24%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

916.20

773.03

18.52%

Operating Profit (PBDIT) excl Other Income

204.48

208.58

-1.97%

Interest

25.57

23.51

8.76%

Exceptional Items

0.00

Standalone Net Profit

118.14

127.27

-7.17%

Operating Profit Margin (Excl OI)

22.32%

26.98%

-4.66%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

1,073.84

Operating Profit (PBDIT) excl Other Income

269.89

Interest

34.29

Exceptional Items

0.00

Standalone Net Profit

167.54

Operating Profit Margin (Excl OI)

25.13%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Rubicon Research Ltd

Rubicon Research Ltd

Small Cap

Pharmaceuticals & Biotechnology

Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as `Rubicon Consultants Private Limited', with the RoC. Subsequently, the Company's name was changed from `Rubicon Consultants Private Limited' to `Rubicon Research Private Limited' to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002.

Company Coordinates

No Company Details Available